Pennant Group, Inc. Segments Disclosure
| Home Health and Hospice Services | Senior Living Services | All Other | Total | |||||||||||||||||||||||
| Year Ended December 31, 2025 | ||||||||||||||||||||||||||
| Segment Revenue | $ | 731,392 | $ | 210,078 | $ | 6,235 | $ | 947,705 | ||||||||||||||||||
| Segment Cost of Services | 610,561 | 149,553 | ||||||||||||||||||||||||
| Segment Adjusted EBITDAR from Operations | $ | 120,831 | $ | 60,525 | $ | 181,356 | ||||||||||||||||||||
| Year Ended December 31, 2024 | ||||||||||||||||||||||||||
| Segment Revenue | $ | 515,344 | $ | 174,767 | $ | 5,129 | $ | 695,240 | ||||||||||||||||||
| Segment Cost of Services | 427,635 | 123,107 | ||||||||||||||||||||||||
| Segment Adjusted EBITDAR from Operations | $ | 87,709 | $ | 51,660 | $ | 139,369 | ||||||||||||||||||||
| Year Ended December 31, 2023 | ||||||||||||||||||||||||||
| Segment Revenue | $ | 385,652 | $ | 148,198 | $ | 11,041 | $ | 544,891 | ||||||||||||||||||
| Segment Cost of Services | 320,046 | 102,904 | ||||||||||||||||||||||||
| Segment Adjusted EBITDAR from Operations | $ | 65,606 | $ | 45,294 | $ | 110,900 | ||||||||||||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Segment Adjusted EBITDAR from Operations | $ | 181,356 | $ | 139,369 | $ | 110,900 | |||||||||||
| Less: Unallocated corporate expenses | 60,455 | 43,587 | 31,704 | ||||||||||||||
| Less: Depreciation and amortization | 8,538 | 6,119 | 5,130 | ||||||||||||||
| Rent—cost of services | 48,700 | 43,029 | 39,759 | ||||||||||||||
| Other income | 422 | 207 | 339 | ||||||||||||||
| Adjustments to Segment EBITDAR from Operations: | |||||||||||||||||
Less: Start-up operations (a) | 182 | 137 | 102 | ||||||||||||||
Share-based compensation expense(b) | 9,036 | 8,242 | 5,565 | ||||||||||||||
Acquisition related costs(c) | 6,587 | 1,278 | 476 | ||||||||||||||
Activities associated with transitioning operations(d) | (880) | (570) | 612 | ||||||||||||||
Transition services costs(e) | 503 | — | — | ||||||||||||||
Unusual, non-recurring, or redundant charges(f) | 113 | 1,004 | 2,575 | ||||||||||||||
| Add: Net income attributable to noncontrolling interest | 4,186 | 1,780 | 531 | ||||||||||||||
| Income from operations | $ | 51,886 | $ | 38,116 | $ | 25,169 | |||||||||||
| (a) | Represents results related to start-up operations. This amount excludes rent and depreciation and amortization expense related to such operations. | |||||||
| (b) | Share-based compensation expense and related payroll taxes incurred. Share-based compensation expense and related payroll taxes are included in cost of services and general and administrative expense. | |||||||
| (c) | Non-capitalizable costs associated with acquisitions and write-offs for amounts in dispute with the prior owners of certain acquired operations. | |||||||
| (d) | During the year ended December 31, 2023, an affiliate of the Company placed its memory care units into transition and is converting the facility into an assisted living community. We received insurance proceeds related to the property in 2024 and 2025 which were recorded in gain on disposition of property and equipment, net on the consolidated statements of income. The amounts reported exclude rent and depreciation and amortization expense related to such operations. | |||||||
| (e) | Costs identified as redundant or non-recurring incurred by the Company as a result of the transition services agreement between the Company and UnitedHealth entered into as part of the acquisition agreement. All amounts are included in Cost of services. Fees incurred under the transition services agreement were $3,001 for the year ended December 31, 2025. | |||||||
| (f) | Represents unusual, non-recurring, or redundant charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses. | |||||||
| Adjusted segment depreciation expense | Home Health and Hospice Services | Senior Living Services | ||||||||||||
| Year Ended December 31, 2025 | $ | 1,066 | $ | 4,740 | ||||||||||
| Year Ended December 31, 2024 | $ | 870 | $ | 4,107 | ||||||||||
| Year Ended December 31, 2023 | $ | 1,208 | $ | 3,452 | ||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 26, 2026 | Showing above |
| 2024 | Feb 27, 2025 | |
| 2023 | Feb 28, 2024 | |
| 2022 | Feb 23, 2023 | |
| 2021 | Feb 28, 2022 | |
| 2020 | Feb 24, 2021 | |
| 2019 | Mar 4, 2020 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.